Cargando…
Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy
Upper lid retraction (ULR) is the most common and earliest symptom in thyroid-associated ophthalmopathy (TAO) patients. Surgical correction is effective for ULR in stable diseases. However, non-invasive treatment is also required for the TAO patient in active phase. Here, we reported a complex case...
Autores principales: | Yang, Jing, Hu, Xiuyu, Li, Qingfeng, Huang, Ru-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292564/ https://www.ncbi.nlm.nih.gov/pubmed/37221639 http://dx.doi.org/10.1097/SCS.0000000000009347 |
Ejemplares similares
-
Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy
por: Li, Dongping, et al.
Publicado: (2021) -
Comparison between hyaluronic acid filler and botulinum toxin type A in the treatment of thyroid upper eyelid retraction
por: Hassan Hussien, Mahaa, et al.
Publicado: (2020) -
Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto’s thyroiditis and ophthalmopathy or isolated upper eyelid retraction
por: Wall, Jack R, et al.
Publicado: (2014) -
Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm
por: Yang, Hui, et al.
Publicado: (2016) -
The role of botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery
por: Dash, Sandip Kumar
Publicado: (2008)